
Restart Life Sciences Corp.
Restart Life Sciences Corp. (NMLSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NMLSF · as of Jun 15, 2026
Key Statistics
Explore Restart Life Sciences Corp. Data
nmlsf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
nmlsf competitorsStock Performance
Full HistoryAbout Restart Life Sciences Corp.
Restart Life Sciences Corp. functions as a biotechnology firm, with its primary focus being the exploration and advancement of psilocybin. The company's offerings encompass therapeutic treatments and …
what is restart life sciences corp. · nmlsf stock overview · restart life sciences corp. company profile · who is restart life sciences corp. ceo · nmlsf OTC · restart life sciences corp. headquarters · restart life sciences corp. business segments
About Stock Overview & Key Data
Restart Life Sciences Corp. (NMLSF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 27, 2008. As of the latest trading session, NMLSF stock price is $0.04, with a market capitalization of $1.3M. The stock has returned -24.08% over the past 12 months and -59.53% year-to-date.
In fiscal year 2025, Restart Life Sciences Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Restart Life Sciences Corp. (NMLSF) stock price is $0.04. The stock is traded on OTC under the ticker symbol NMLSF. The 52-week range is $0.01 – $0.12.